Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Hepatitis E Vaccine (Escherichia coli expression)

Recombinant Hepatitis E Vaccine · Xiamen Innovax Biotech Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Hepatitis E Vaccine (Escherichia coli expression), covering 2019-02-21 to 2019-02-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule) [Phase 4]

See pricing